COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 812

Article download: 191

IP Indian Journal of Immunology and Respiratory Medicine


Prompt surgical debridement with adequate antifungal treatment as effective combination therapy for pulmonary mucormycosis


Full Text PDF Share on Facebook Share on Twitter


Author Details : Shegu Gilbert, Devender Singh, Sangita Sharma Mehta, Sivakumar M

Volume : 1, Issue : 2, Year : 2016

Article Page : 37-39


Suggest article by email

Abstract

Pulmonary mucormycosis is an emerging life threatening fungal infection in the recent years. Immunocompromised patients and those with uncontrolled diabetes mellitus are exclusively affected by this infection. It carries a high mortality (40–76%) and morbidity. Here we present a patient, an elderly diabetic with fever and a cavity in the lung. He underwent lingulectomy and left lower lobectomy surgery. Histopathological examination of the specimen revealed numerous broad aseptate foldable fungal hyphae and sporangium suggesting pulmonary mucormycosis. He was treated with amphotericin B for six weeks. The patient was symptom free at his third month follow- up visit.

Keywords:
 Mucormycosis/Etiology, Lung diseases, Amphotericin B/Therapeutic use

How to cite : Gilbert S, Singh D, Mehta S S, Sivakumar M, Prompt surgical debridement with adequate antifungal treatment as effective combination therapy for pulmonary mucormycosis. IP Indian J Immunol Respir Med 2016;1(2):37-39

Copyright © 2016 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)